353 related articles for article (PubMed ID: 31801390)
1. Anti-hydroxy-3-methylglutaryl-coenzyme A reductase (anti-HMGCR) antibody in necrotizing myopathy: treatment outcomes, cancer risk, and role of autoantibody level.
Aggarwal R; Moghadam-Kia S; Lacomis D; Malik A; Qi Z; Koontz D; Burlingame RW; Oddis CV
Scand J Rheumatol; 2020 Sep; 49(5):405-411. PubMed ID: 31801390
[No Abstract] [Full Text] [Related]
2. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China.
Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J
J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933
[TBL] [Abstract][Full Text] [Related]
3. More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Tiniakou E; Pinal-Fernandez I; Lloyd TE; Albayda J; Paik J; Werner JL; Parks CA; Casciola-Rosen L; Christopher-Stine L; Mammen AL
Rheumatology (Oxford); 2017 May; 56(5):787-794. PubMed ID: 28096458
[TBL] [Abstract][Full Text] [Related]
4. Association of Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Autoantibodies With DRB1*07:01 and Severe Myositis in Juvenile Myositis Patients.
Kishi T; Rider LG; Pak K; Barillas-Arias L; Henrickson M; McCarthy PL; Shaham B; Weiss PF; Horkayne-Szakaly I; Targoff IN; Miller FW; Mammen AL;
Arthritis Care Res (Hoboken); 2017 Jul; 69(7):1088-1094. PubMed ID: 28129483
[TBL] [Abstract][Full Text] [Related]
5. Statins and myotoxic effects associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: an observational study in Japan.
Watanabe Y; Suzuki S; Nishimura H; Murata KY; Kurashige T; Ikawa M; Asahi M; Konishi H; Mitsuma S; Kawabata S; Suzuki N; Nishino I
Medicine (Baltimore); 2015 Jan; 94(4):e416. PubMed ID: 25634171
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and prognosis in anti-SRP and anti-HMGCR necrotising myopathy.
Watanabe Y; Uruha A; Suzuki S; Nakahara J; Hamanaka K; Takayama K; Suzuki N; Nishino I
J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1038-44. PubMed ID: 27147697
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy.
Mammen AL; Chung T; Christopher-Stine L; Rosen P; Rosen A; Doering KR; Casciola-Rosen LA
Arthritis Rheum; 2011 Mar; 63(3):713-21. PubMed ID: 21360500
[TBL] [Abstract][Full Text] [Related]
8. Proposed cut-off for reactivity of anti-HMGCR and anti-SRP antibodies in patients statin-exposed and statin-unexposed.
Carvalho AAS; Silva VGD; Vieira TF; Delgado PO; Corazini R; Feder D; Fonseca FLA
Medicine (Baltimore); 2018 Aug; 97(35):e11858. PubMed ID: 30170376
[TBL] [Abstract][Full Text] [Related]
9. Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy.
Werner JL; Christopher-Stine L; Ghazarian SR; Pak KS; Kus JE; Daya NR; Lloyd TE; Mammen AL
Arthritis Rheum; 2012 Dec; 64(12):4087-93. PubMed ID: 22933019
[TBL] [Abstract][Full Text] [Related]
10. Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies.
Ge Y; Lu X; Peng Q; Shu X; Wang G
PLoS One; 2015; 10(10):e0141616. PubMed ID: 26509687
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of anti-HMGCR and anti-MDA5 identified by an unlabeled immunoprecipitation assay in a chinese patient cohort with myositis.
Huang L; Wang L; Yang Y; Chen H; Liu Y; Liu K; Liu M; Xiao Y; Zuo X; Li Y; Luo H; Zhang H; Xiao X
Medicine (Baltimore); 2018 Nov; 97(47):e13236. PubMed ID: 30461626
[TBL] [Abstract][Full Text] [Related]
12. Clinical associations of patients with anti-3-hydroxy-3-methylglutaryl CoA reductase antibody-associated immune-mediated necrotising myopathy.
Tan E; Knight J; Khonasti S; Nolan D; McGettigan B; Bundell C; Needham M; Brusch A
Intern Med J; 2023 Oct; 53(10):1846-1853. PubMed ID: 36625419
[TBL] [Abstract][Full Text] [Related]
13. Pediatric necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies.
Liang WC; Uruha A; Suzuki S; Murakami N; Takeshita E; Chen WZ; Jong YJ; Endo Y; Komaki H; Fujii T; Kawano Y; Mori-Yoshimura M; Oya Y; Xi J; Zhu W; Zhao C; Watanabe Y; Ikemoto K; Nishikawa A; Hamanaka K; Mitsuhashi S; Suzuki N; Nishino I
Rheumatology (Oxford); 2017 Feb; 56(2):287-293. PubMed ID: 27818386
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal Course of Disease in a Large Cohort of Myositis Patients With Autoantibodies Recognizing the Signal Recognition Particle.
Pinal-Fernandez I; Parks C; Werner JL; Albayda J; Paik J; Danoff SK; Casciola-Rosen L; Christopher-Stine L; Mammen AL
Arthritis Care Res (Hoboken); 2017 Feb; 69(2):263-270. PubMed ID: 27111848
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous involvement in anti-HMGCR positive necrotizing myopathy.
Williams B; Horn MP; Banz Y; Feldmeyer L; Villiger PM
J Autoimmun; 2021 Sep; 123():102691. PubMed ID: 34332436
[TBL] [Abstract][Full Text] [Related]
16. Immune-Mediated Necrotizing Myopathy.
Pinal-Fernandez I; Casal-Dominguez M; Mammen AL
Curr Rheumatol Rep; 2018 Mar; 20(4):21. PubMed ID: 29582188
[TBL] [Abstract][Full Text] [Related]
17. Mitophagy in three cases of immune-mediated necrotizing myopathy associated with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase autoantibodies: ultrastructural and immunohistochemical studies.
Matsubara S; Bokuda K; Asano Y; Morishima R; Sugaya K; Miyamoto K; Koide R; Komori T; Suzuki S; Nishino I
Neuromuscul Disord; 2018 Mar; 28(3):283-288. PubMed ID: 29402601
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune necrotising myopathy and HMGCR antibodies.
Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S
Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058
[TBL] [Abstract][Full Text] [Related]
19. Analysis of autoantibodies to 3-hydroxy-3-methylglutaryl-coenzyme A reductase using different technologies.
Musset L; Miyara M; Benveniste O; Charuel JL; Shikhman A; Boyer O; Fowler R; Mammen A; Phillips J; Mahler M
J Immunol Res; 2014; 2014():405956. PubMed ID: 24741598
[TBL] [Abstract][Full Text] [Related]
20. Rituximab in the Treatment of Refractory Anti-HMGCR Immune-mediated Necrotizing Myopathy.
Landon-Cardinal O; Allenbach Y; Soulages A; Rigolet A; Hervier B; Champtiaux N; Monzani Q; Solé G; Benveniste O
J Rheumatol; 2019 Jun; 46(6):623-627. PubMed ID: 30554155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
